WuXi Biologics
Pharmaceutical Manufacturing • 
Binhu District, Jiangsu, China • 2001-5000 Employees
Company overview
| Headquarters | 108 Meiliang Road, Mashan, Binhu District, Wuxi, Jiangsu, China, 214092, Wuxi, Jiangsu 214092, CN |
| Phone number | +8651081831205 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Analytical Services, Biopharmaceuticals, Formulation Development, Biotherapeutics, Biosafety, Vaccine Manufacturing, Cell Line Development, Vaccine Development, Protein Production, Antibody Discovery, Monoclonal Antibodies (Mabs), Continuous Manufacturing, Analytical Characterization, Biologics Gmp Manufacturing, Biologics Conjugation, Biologics Discovery Service, Bioprocess Cmc, Cell Culture And Purification Process Development, Antibody Manufacturing |
| Employees | 2001-5000 |
| Socials |
WuXi Biologics Email Formats
WuXi Biologics uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@wuxibiologics.com), used 82.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@wuxibiologics.com | 82.9% |
{first initial}.{last name} | j.doe@wuxibiologics.com | 13.2% |
{first initial}_{last name} | j_doe@wuxibiologics.com | 1.5% |
{last name}.{first initial} | doe.j@wuxibiologics.com | 1.4% |
About WuXi Biologics
Our Vision: “Every drug can be made and every disease can be treated” by building an open-access platform with the most comprehensive capabilities and technologies in the global biologics industry. Our Mission: To accelerate and transform the discovery, development and manufacturing of biologics through a comprehensive open-access platform, enabling our global healthcare partners and benefiting patients worldwide. Our Company: WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing. The company’s history and achievements demonstrate its commitment to providing a truly ONE-stop service offering and strong value proposition to its global clients. With total estimated capacity for biopharmaceutical production planned in the U.S., China, Ireland, Germany, and Singapore exceeding 430,000 liters after 2024, WuXi Biologics will provide its biomanufacturing partners with a robust and premier-quality global supply chain network.
WuXi Biologics revenue & valuation
| Annual revenue | $2,402,700,000 |
| Revenue per employee | $835,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $7,688,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 2001-5000
Seniority
Employees
Employees by Department
WuXi Biologics has 883 employees across 21 departments.
Departments
Number of employees
WuXi Biologics Tech Stack
Discover the technologies and tools that power WuXi Biologics's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Analytics
JavaScript libraries
Marketing automation
JavaScript libraries
Advertising
Programming languages
Security
Advertising
Blogs
Page builders
Germany
United States
United Kingdom
Netherlands
IrelandFrequently asked questions
Key Contact at WuXi Biologics
4.8
40,000 users
